A

Alliance Pharma PLC
LSE:APH

Watchlist Manager
Alliance Pharma PLC
LSE:APH
Watchlist
Price: 64.7 GBX Market Closed
Market Cap: 356.5m GBX

Wall Street
Price Targets

APH Price Targets Summary
Alliance Pharma PLC

There are no price targets for APH.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Alliance Pharma PLC Competitors:
Price Targets
AUROPHARMA
Aurobindo Pharma Ltd
15% Upside
4523
Eisai Co Ltd
6% Upside
GRANULES
Granules India Ltd
6% Upside
2M7C
China Medical System Holdings Ltd
17% Upside
NUVB
Nuvation Bio Inc
70% Upside
COHANCE
Cohance Lifesciences Ltd
85% Upside
000423
Dong-E-E-Jiao Co Ltd
56% Upside
RPRX
Royalty Pharma PLC
15% Upside

Revenue
Forecast

Revenue Estimate
Alliance Pharma PLC

For the last 13 years the compound annual growth rate for Alliance Pharma PLC's revenue is 11%. The projected CAGR for the next 3 years is 9%.

11%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Alliance Pharma PLC

For the last 13 years the compound annual growth rate for Alliance Pharma PLC's operating income is 8%. The projected CAGR for the next 3 years is 16%.

8%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
Alliance Pharma PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-51%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is APH's stock price target?
Not Available

APH doesn't have any price targets made by Wall Street professionals.

What is Alliance Pharma PLC's Revenue forecast?
Projected CAGR
9%

For the last 13 years the compound annual growth rate for Alliance Pharma PLC's revenue is 11%. The projected CAGR for the next 3 years is 9%.

What is Alliance Pharma PLC's Operating Income forecast?
Projected CAGR
16%

For the last 13 years the compound annual growth rate for Alliance Pharma PLC's operating income is 8%. The projected CAGR for the next 3 years is 16%.

Back to Top